222

JACOBSON PHARMA CO LTD

No trades
See on Supercharts
Market capitalization
‪1.10 B‬HKD
‪251.04 M‬HKD
‪1.79 B‬HKD
‪402.40 M‬
Beta (1Y)
0.71

About JACOBSON PHARMA CO LTD

CEO
Kwong Yip Sum
Headquarters
Hong Kong
Employees (FY)
‪1.79 K‬
Founded
2016
ISIN
KYG677291067
FIGI
BBG00DRGW9B9
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. It operates through the following segments: Generic Drugs, Branded Healthcare, and Wholesale and Retail. The Generic Drugs segment develops, manufactures and distributes a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment develops, manufactures and/or distributes branded medicines, proprietary Chinese medicines and health and wellness products. The Wholesale and Retail segment sells western and proprietary medicine in Hong Kong. The company was founded by Kwong Yip Sum on February 16, 2016 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2633 is 0.57 HKD — it has decreased by 1.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JACOBSON PHARMA CO LTD stocks are traded under the ticker 2633.
JACOBSON PHARMA CO LTD is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
2633 stock is 3.57% volatile and has beta coefficient of 0.71. Check out the list of the most volatile stocks — is JACOBSON PHARMA CO LTD there?
Yes, you can track JACOBSON PHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
2633 stock has fallen by 3.39% compared to the previous week, the month change is a 5.00% fall, over the last year JACOBSON PHARMA CO LTD has showed a 37.36% decrease.
2633 net income for the last quarter is ‪125.82 M‬ HKD, while the quarter before that showed ‪114.85 M‬ HKD of net income which accounts for 9.55% change. Track more JACOBSON PHARMA CO LTD financial stats to get the full picture.
Today JACOBSON PHARMA CO LTD has the market capitalization of ‪1.15 B‬, it has decreased by 1.72% over the last week.
JACOBSON PHARMA CO LTD dividend yield was 5.34% in 2022, and payout ratio reached 39.45%. The year before the numbers were 5.97% and 41.86% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2633 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JACOBSON PHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
2633 reached its all-time high on Aug 8, 2017 with the price of 2.28 HKD, and its all-time low was 0.44 HKD and was reached on Dec 17, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.79 K‬ employees. See our rating of the largest employees — is JACOBSON PHARMA CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JACOBSON PHARMA CO LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JACOBSON PHARMA CO LTD stock shows the sell signal. See more of JACOBSON PHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JACOBSON PHARMA CO LTD EBITDA is ‪468.65 M‬ HKD, and current EBITDA margin is 28.20%. See more stats in JACOBSON PHARMA CO LTD financial statements.